RHODE ISLAND HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $65.1M
- Transactions
- 5,793
- Companies
- 40
- Average per transaction
- $11,237
Who reported the payments
| Regeneron | $8,020,838 |
| Genentech, Inc. | $6,395,160 |
| AstraZeneca | $6,117,095 |
| AbbVie | $5,643,081 |
| Biogen | $4,793,885 |
| Pfizer | $3,246,798 |
| Daiichi Sankyo Inc. | $3,200,124 |
| Merck | $2,279,302 |
| E.r. Squibb & Sons, L.L.C. | $1,992,586 |
| Astrazeneca UK Limited | $1,848,403 |
| Eli Lilly | $1,679,107 |
| Eisai Inc. | $1,542,129 |
| Sanofi US Services Inc. | $1,493,449 |
| EMD Serono, Inc. | $1,292,823 |
| Novartis | $810,220 |
| Trisalus Life Sciences, Inc. | $656,115 |
| United Therapeutics Corporation | $653,158 |
| Chugai Pharmaceutical Co., Ltd. | $632,445 |
| Genmab U.S., Inc. | $620,834 |
| Amgen | $576,235 |
| CSL Behring | $511,121 |
| Bayer | $502,469 |
| Sun Pharmaceutical Industries Inc. | $467,890 |
| Jazz Pharmaceuticals Inc. | $467,876 |
| F. Hoffmann-la Roche AG | $426,178 |
| Sanofi Pasteur Inc. | $403,711 |
| Biofire Diagnostics, LLC | $388,907 |
| Takeda Pharmaceuticals U.S.A., Inc. | $380,047 |
| Tosoh Bioscience, Inc. | $371,450 |
| Novocure GmbH | $348,252 |
| Seagen Inc. | $346,519 |
| Ipsen Biopharmaceuticals, Inc | $344,447 |
| Roche Products Limited | $311,175 |
| Bristol Myers Squibb | $299,984 |
| Abbott | $297,857 |
| Incyte Corporation | $290,055 |
| Vertex | $272,520 |
| Kls-martin L.p. | $270,000 |
| Hoffmann-la Roche Limited | $258,959 |
| Mallinckrodt Enterprises LLC | $250,763 |